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High performance liquid chromatography for simultaneous 
determination of xipamide, triamterene and hydrochlorothiazide 
in bulk drug samples and dosage forms
A novel, simple and robust high-performance liquid chro-
matography (HPLC) method was developed and validated 
for simultaneous determination of xipamide (XIP), triam-
terene (TRI) and hydrochlorothiazide (HCT) in their bulk 
powders and dosage forms. Chromatographic separation 
was carried out in less than two minutes. The separation 
was performed on a RP C-18 stationary phase with an iso-
cratic elution system consisting of 0.03 mol L–1 orthophos-
phoric acid (pH 2.3) and acetonitrile (ACN) as the mobile 
phase in the ratio of 50:50, at 2.0 mL min–1 fl ow rate at room 
temperature. Detection was performed at 220 nm. Valida-
tion was performed concerning system suitability, limits of 
detection and quantitation, accuracy, precision, linearity 
and robustness. Calibration curves were rectilinear over 
the range of 0.195–100 μg mL–1 for all the drugs studied. 
Recovery values were 99.9, 99.6 and 99.0 % for XIP, TRI and 
HCT, respectively. The method was applied to simultane-
ous determination of the studied analytes in their pharma-
ceutical dosage forms.
Keywords: xipamide, triamterene, hydrochlorothiazide, 
HPLC, simultaneous analysis
Xipamide (XIP, 4-chloro-2,6-dimethyl-5-sulfamoylsalicylanilide) (1) is used for high 
blood pressure and edema control with a moderately powerful diuretic action (2). Several 
procedures have been developed for its determination, which include spectrophotometry 
(3–5), spectrofl uorimetry (5,6), TLC-densitometry (4) and HPLC (7–12).
Triamterene (TRI, 6-phenyl-2,4,7-triaminopteridine) (1) is a relatively ineffi  cient anti-
hypertensive when used alone; hence it is used in combination with some potent diuretic 
(e.g., anthranilic acid or thiazide derivative) to give a synergistic action (13). Literature 
survey reveals that TRI has been determined by spectrophotometric (4, 14–18), fl uorimetric 
(19, 20) and chromatographic (7, 21, 22) methods.
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Hydrochlorothiazide (HCT, 6-chloro-3,4-dihydro-2H-1,2,4- benzothiadiazine-7-sulphon-
amide-1,1-dioxide) (1) is used as an eff ective diuretic and antihypertensive agent. Previous 
methods described for HCT determination include spectrophotometry (15–17, 23), HPTLC 
with fl uorimetric detection (23) and HPLC (17, 21, 24–26).
Literature review revealed that a few methods were developed for determination of 
XIP and TRI together (4, 7) or TRI with HCT (15–17, 21); however, these methods suff er ei-
ther from low sensitivity or long separation time. In addition, the single-pill, triple-combi-
nation antihypertensive therapy has been widely accepted as an eff ective, well-tolerated, 
and convenient strategy that can help hypertensive patients (27). Nevertheless, nowadays 
there is no one dosage form that includes the three drugs analyzed in this study all to-
gether. Therefore, the development of a simple, reproducible and sensitive HPLC method 
for their simultaneous determination in a mixture of bulk drug samples or in a combined 
dosage form would be very important.
Chemical structures of all three analytes are given in Fig. 1. 
EXPERIMENTAL
Materials and reagents
Analytical HPLC grade solvents were used in all experiments, including methanol 
and ACN (POCH S.A., Poland). Orthophosphoric acid 85 % and sodium hydroxide (Burdick 
& Jackson, USA) were used. Double distilled water was used. Xipamide (99.09 %), triam-
terene (99.91 %) and hydrochlorothiazide (99.50 %) were kindly supplied by EIPICO Phar-
maceutical Industries Company, Egypt. The pharmaceutical dosage forms used were 
Epitens® (Egyptian International Pharmaceutical Industry Co, Egypt, 30 mg TRI and 10 mg 
XIP per tablet) and Moduretic® (Kahira Company for Pharmaceuticals, Egypt, 50 mg HCT 
and 5 mg amiloride per tablet). There is no formulation in the Egyptian market that in-
cludes HCT only. This is why Moduretic®, containing HCT and amiloride, was analyzed 
for HCT contents.
Chromatographic conditions
HPLC apparatus (Agilent 1100, Agilent, USA) composed of a quaternary pump G1310A 
with quaternary solvent cabinet, vacuum degasser G1322A and a four-channel gradient 
pump, autosampler G1313A, variable wavelength detector G1314A with standard 10-mm 
pathlength-fl ow cell (14 μL volume, 4 x 106 Pa maximum pressure). Separations were per-
formed on an Agilent 5-μm Hypersil BDS C18 column (150 x 4.6 mm i.d.). A pH meter 
Jenway 4330 (Jenway, UK) was used.
Fig. 1. Chemical structures of the analytes.
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Validation
For the determination of XIP, TRI and HCT, an isocratic mobile phase consisting of 
ACN : 0.03 mol L–1 H3PO4 (pH 2.3) (50:50, V/V) at a fl ow rate of 2.0 mL min–1 was applied. 
pH readings always belong to the aqueous part of the mobile phase. For each run, 10 μL of 
sample was injected. Detection was achieved at 220 nm.
The proposed analytical method was validated through linearity, limits of detection 
and quantitation, accuracy, precision and robustness according to the guidelines (28–30). 
The limits of detection (LOD) and quantifi cation (LOQ) (29, 30) were defi ned as the injected 
quantities giving a signal-to-noise of 3 and 10, respectively, in terms of peak height (Table 
I).
To obtain calibration graphs, drug concentrations in the range of 0.195–100 μg mL–1 
were used. Peak areas were plott ed against the corresponding injected concentrations.
Checking of chromatographic parameters was done using the standard mixture solu-
tion. They include retention time, resolution (Rs), selectivity factor (α), symmetry and N 
(theoretical plates) (Table I).
The precision study was performed by injection of the standard solution at four con-
centrations four times during a day or every day for four days in case of intra-day and 
inter-day precision, respectively (Table II).
Table I. Chromatographic, linear regression and limiting data for the determination of
XIP, TRI, and HCT using the proposed HPLC method
Parameter Xipamide Triamterene Hydrochlorothiazide
Chromatographic parameters
tR ± SD (min) 1.853 ± 0.002 1.493 ± 0.002 0.961 ± 0.001
Resolution (Rs) 3.17 4.50 –
Selectivity (α) 1.415 2.575 –
Symmetry 0.860 0.630 0.680
k´ 1.973 1.397 0.54
N (150 mm column) 5607 2197.5 1252.75
Linearity and regression data
Linearity range (μg mL–1) 0.195–100 0.195–100 0.195–100
LOD (μg mL–1) 0.012 0.024 0.012
LOQ (μg mL–1) 0.04 0.08 0.04
Slope ± RSDa 47.518 ± 0.01 40.429 ± 0.02 32.806 ± 0.03
Intercept ± RSDa 0.4696 ± 1.6 3.8595 ± 1.3 2.3953 ± 2.5
Coeffi  cient of determination (R2) 0.9999 0.9999 0.9999
a RSD (%)
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Stability of the standard solution was checked through injection of the prepared solu-
tion at intervals into the chromatograph for up to about 7 days.
Robustness of the method was studied for small changes in the fl ow rate (± 0.1 mL 
min–1), % of ACN (± 0.5 %), wavelength of detection (± 1 nm) and injection volume (± 0.5 
μL).
Preparation of standard solutions
Ten mg of XIP, TRI and HCT were dissolved in 10 mL methanol and then completed 
to 100 mL with H2O to give the stock solution (0.1 mg mL–1). Working standard solutions 
were prepared by diluting aliquots of stock solutions with the same diluting solvent (10 % 
methanol in water) to obtain concentrations ranging from 0.195–100 μg mL–1 for all the 
studied drugs.
Assay of tablets
Ten tablets of Epitens® and Moduretic® were fi nely powdered, separately. An accu-
rately weighed quantity of the powders equivalent to 30 mg TRI and 10 mg XIP in case of 
Epitens® and equivalent to 50 mg HCT in case of Moduretic® tablets were transferred into 
100-mL volumetric fl asks and extracted using 10 mL methanol and then completed to 100 
mL with water. The fl asks were shaken for 15 min using an ultrasonic shaker and then 
fi ltered into dry conical fl asks. Aliquots of the fi ltrates (25 and 10 mL) of Epitens® and Mo-
duretic®, respectively, were separately transferred into 100-mL volumetric fl asks and di-
luted to volumes with the diluting solvent to prepare solutions containing 25 μg mL–1 XIP, 














  12.50   96.8 0.1   99.7 1.5
  25.00   97.6 0.1   98.8 1.1
  50.00   99.4 0.4   99.7 0.2
100.00 101.5 0.1 101.3 1.0
Triamterene
  12.50   98.8 0.7   97.3 1.9
  25.00   98.9 0.3   97.3 1.4
  50.00   99.3 0.4   98.4 0.8
100.00 101.1 0.4 100.2 0.8
Hydrochloro-
thiazide
  12.50   99.7 0.7   99.9 1.8
  25.00   99.4 0.5   98.1 1.3
  50.00   99.1 0.2   99.3 0.3
100.00 100.7 0.2 100.9 0.5
a Recovery of the label claim. Mean of four determinations.
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75 μg mL–1 TRI in case of Epitens® tablets and 50 μg mL–1 HCT in case of Moduretic® tab-
lets.
Epitens® tablets extract (XIP and TRI) and Moduretic® tablets extract (HCT) were de-
termined separately.
Also, a laboratory prepared mixture composed of tablet solutions of XIP and TRI 
(Epitens®) and HCT (Moduretic®) was prepared and then analyzed.
RESULTS AND DISCUSSION
Method optimization
Optimization of diff erent experimental conditions was carried out at the detection 
wavelength of 220 nm, which gives the best sensitivity for all three analytes.
Elution of TRI, XIP and HCT was achieved at reasonable retention times (2 minutes) 
using 50 % ACN in the mobile phase (Fig. 2). Longer retention times were obtained at 
lower concentrations of ACN, while increasing the ACN concentration to 60 % led to over-
lap of XIP with TRI peaks (eluted together at 1.571 min). pH 2.3 of the aqueous part of the 
mobile phase was chosen as the optimum pH providing the best peak symmetry and 
sharpness adding to reasonable separation, retention times and peak shape.
Validation
Linearity and limiting values. – The results indicate that there is a wide linearity range 
(0.195–100 μg mL–1 with R2 > 0.999) as well as low LOD (0.01–0.02 μg mL–1) and LOQ (0.04–
0.08 μg mL–1) values. Resolution is greater than 1.5 and symmetry factors for all analytes 
are 0.6–0.9 (see Table I).
Fig. 2. Typical chromatogram of a 10-μL injection of a standard mixture of 100 μg mL–1 XIP, TRI and 
HCT using 0.03 mol L–1 orthophosphoric acid (pH 2.3) and ACN (50:50) as the mobile phase at a fl ow 
rate of 2.0 mL min–1 and detection at 220 nm.
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Selectivity and specifi city of the method. – The presence of amiloride co-formulated with 
HCT did not aff ect separation and quantitation of HCT. We assume that the peak at 1.3 min 
may be ascribed to amiloride. We can also conclude that there was no interference of other 
additives in the formulations (Fig. 3). Detection and validated quantitation of amiloride is 
our next task.
Precision. – Good intra- and inter-day precision was indicated by RSD values of 0.1–0.7 
and 0.2–1.9 %, resp. (Table II).
Stability and robustness. – The results of stability tests reveal that the RSD of the peak 
area was within 1.0 %. The results of robustness studies indicated that the method is much 
more sensitive to slight variations in the fl ow rate (Figs. 4a and b) and % of ACN (Figs. 4c 
and d) with RSD values within 3.9 %. The decrease in ACN percentage led to an increase 
of retention times for all the studied drugs. Small changes in the wavelength of detection 
and injection volume had no signifi cant eff ect on the peak area and retention time for all 
the studied drugs (RSD values lower than 1.0 %, Table III).
Accuracy of the new method and application for analysis of XIP, TRI and HCT in tablets
Laboratory prepared mixture (containing all analytes) was composed of Epitens® and 
Moduretic® tablet solutions. The analysis has shown good accuracy with good recoveries 
of the label claim (mean ± RSD, n = 3) 98.9 ± 1.1, 97.8 ± 1.4 and 99.1 ± 1.5 % for XIP, TRI and 
HCT, respectively (Table IV). For all three analytes, the model accuracy obtained from 
standard solutions within the linearity range covers the interval of 97 to 102 % (Table II).
Fig. 3. Application of the proposed HPLC method for the determination of:a) XIP, TRI in Epitens® 
tablets, b) HCT in Moduretic® tablets, c) laboratory prepared mixture of the tablet solutions (XIP and 
TRI from Epitens®, HCT from Moduretic®, under optimized chromatographic conditions.
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Fig. 4. Robustness of the proposed HPLC method from a typical chromatogram of a 10-μL injection 
of a standard mixture of 100 μg mL–1 XIP, TRI and HCT: a) fl ow rate 1.9 mL min–1, b) fl ow rate 2.1 mL 
min–1, c) 49.5 % ACN, d) 50.5 % ACN. Other conditions are as optimized.










9.5 10.5 219 221 1.9 2.1
X
IP   50 0.2 0.0 0.1 0.0 3.4 3.4
100 0.0 0.2 0.1 0.9 3.7 3.1
TR
I   50 0.1 0.1 0.0 0.1 3.6 3.9
100 0.1 0.0 0.1 0.1 3.6 3.7
H
C
T   50 0.3 0.1 0.3 0.2 3.6 3.9
100 0.1 0.1 0.1 0.4 3.7 3.7
Table IV. Application of the proposed HPLC method for simultaneous determination of 














  8.33 99.8 25.00 96.8 16.66   98.1
12.50 98.2 37.50 98.7 25.00 100.2
Meana 98.9 97.8   99.1
 RSD (%)   1.2   1.4    1.5
a Average of four experiments.
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When the results of the method for determination of the three analytes were statisti-
cally compared with those obtained from the reported HPLC methods (7, 24), it was found 
that there was no signifi cant diff erence between them regarding accuracy and precision, 
since the calculated t- and F-values were lower than the corresponding tabulated ones 
(Table V).
CONCLUSIONS
A simple, fast and specifi c HPLC method has been described for simultaneous deter-
mination of xipamide, triamterene and hydrochlorothiazide in their pure form and in 
pharmaceutical preparations. The proposed method is of great interest for routine sample 
analysis and quality control of the analyzed drugs because of the short chromatographic 
run time (2 minutes) allowing a large sample throughput. When compared to the previ-
ously reported methods, the new method is simple, cost eff ective, precise, sensitive and 
accurate.
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